Wills Eye Hospital | Neuro

Research site

Site insights

Top conditions

Top treatments

VRDN 001

Parent organization

This site is a part of Wills Eye Hospital

Data sourced from

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 4 total trials

A Safety, Tolerability and Efficacy Study of VRDN 001 in Healthy Volunteers and Persons With Thyroid Eye Disease (TED) (THRIVE)

Please note that Phase 1/2 (HV \& MAD) cohort - recruitment is completed and Phase 3 Component (THRIVE) - is actively recruiting.The investigational...

Active, not recruiting
Thyroid Eye Disease
Drug: VRDN-001 Placebo
Drug: VRDN-001 Phase 3 Cohort (THRIVE)

Trial sponsors


Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems